Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models

S Brandl, M Reindl - International Journal of Molecular Sciences, 2023 - mdpi.com
The blood–brain barrier, which is formed by tightly interconnected microvascular endothelial
cells, separates the brain from the peripheral circulation. Together with other central nervous …

Nature-inspired solutions: A comprehensive review of biomimetic nanoparticles in nanomedicine

E Issaka, B Tornyeava, EA Agyekum… - Journal of …, 2024 - journals.sagepub.com
Biomimetic nanoparticles (BioM NPs) are an innovative strategy for nanomedicine
(NanoMed) that combines the advantages of artificial materials with the biological …

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

X Li, JS Oh, Y Lee, EC Lee, M Yang, N Kwon… - Biomaterials …, 2023 - spj.science.org
Background Malignant glioma is among the most lethal and frequently occurring brain
tumors, and the average survival period is 15 months. Existing chemotherapy has low …

A Rapid-Patterning 3D Vessel-on-Chip for Imaging and Quantitatively Analyzing Cell–Cell Junction Phenotypes

L Yan, CW Dwiggins, U Gupta, KM Stroka - Bioengineering, 2023 - mdpi.com
The blood-brain barrier (BBB) is a dynamic interface that regulates the molecular exchanges
between the brain and peripheral blood. The permeability of the BBB is primarily regulated …

Environmental aluminum oxide inducing neurodegeneration in human neurovascular unit with immunity

Y Xue, M Tran, YN Diep, S Shin, J Lee, H Cho… - Scientific Reports, 2024 - nature.com
Aluminum oxide nanoparticle (AlNP), a ubiquitous neurotoxin highly enriched in air
pollution, is often produced as an inevitable byproduct in the manufacturing of industrial …

Advancing Central Nervous System Drug Delivery with Microtubule-Dependent Transcytosis of Novel Aqueous Compounds

M Zhang, S Zhong, L An, P **ang, N Hu… - Biomaterials …, 2024 - pmc.ncbi.nlm.nih.gov
The challenge of delivering therapeutics to the central nervous system due to the restrictive
nature of the blood–brain barrier (BBB) is a substantial hurdle in neuropharmacology. Our …

[HTML][HTML] Mechanisms and Virulence Factors of Cryptococcus neoformans Dissemination to the Central Nervous System

AM Al-Huthaifi, BA Radman, AA Al-Alawi, F Mahmood… - Journal of Fungi, 2024 - mdpi.com
Cryptococcosis is a prevalent fungal infection of the central nervous system (CNS) caused
by Cryptococcus neoformans, a yeast with a polysaccharide capsule in the basidiomycete …

Cerebrovascular-Specific Extracellular Matrix Bioink Promotes Blood–Brain Barrier Properties

H Han, S Lee, G Gao, HG Yi, SH Paek… - Biomaterials …, 2024 - spj.science.org
Chronic neuroinflammation is a principal cause of neurodegenerative diseases such as
Alzheimer's disease and Parkinson's disease. The blood–brain barrier predominantly …

Advancing Central Nervous System Drug Delivery with Microtubule-Dependent Transcytosis of Novel Aqueous Compounds

M Zhang, S Zhong, L An, P **ang, N Hu… - Biomaterials …, 2024 - spj.science.org
The challenge of delivering therapeutics to the central nervous system due to the restrictive
nature of the blood–brain barrier (BBB) is a substantial hurdle in neuropharmacology. Our …

Tension at the gate: sensing mechanical forces at the blood–brain barrier in health and disease

CE Hansen, D Hollaus, A Kamermans… - Journal of …, 2024 - Springer
Microvascular brain endothelial cells tightly limit the entry of blood components and
peripheral cells into the brain by forming the blood–brain barrier (BBB). The BBB is …